Cargando…
Quality of medical therapy in heart failure patients undergoing elective revascularisation: A protective effect of disease modifying therapy at discharge
The STICH(-ES) trial showed that coronary artery bypass grafting was superior to medical therapy alone in treating ischemic heart failure. However, dosages of disease modifying drugs were not reported. We included 128 (84% male, mean age 66 ± 11 years) consecutive patients with ischemic heart failur...
Autores principales: | Wurm, Raphael, Huelsmann, Martin, Hienert, Marius, Seidl, Veronika, Wiedemann, Dominik, Laufer, Guenther, Kocher, Alfred, Adlbrecht, Christopher, Andreas, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668379/ https://www.ncbi.nlm.nih.gov/pubmed/29097746 http://dx.doi.org/10.1038/s41598-017-15004-5 |
Ejemplares similares
-
How to Perfuse: Concepts of Cerebral Protection during Arch Replacement
por: Habertheuer, Andreas, et al.
Publicado: (2015) -
Impact of Subclinical Congestion on Outcome of Patients Undergoing Mitral Valve Surgery
por: Schaefer, Anne-Kristin, et al.
Publicado: (2020) -
Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients
por: Schachner, Thomas, et al.
Publicado: (2010) -
Intermediate-term outcome of 500 consecutive rapid-deployment surgical aortic valve procedures
por: Andreas, Martin, et al.
Publicado: (2019) -
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis
por: Navarese, Eliano P, et al.
Publicado: (2021)